Literature DB >> 20514866

Antisclerotic effect of Trekrezan and its possible mechanisms.

M G Voronkov1, M K Nurbekov, S N Bobkova, L K Karaulova, M I Susova, M M Rasulov.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20514866     DOI： 10.1134/s1607672910020055

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  9 in total

Review 1.  Making and breaking contacts: the cellular biology of cadherin regulation.

Authors:  Alpha S Yap; Matthew S Crampton; Jeff Hardin
Journal:  Curr Opin Cell Biol       Date:  2007-10       Impact factor: 8.382

2.  Tryptophanyl-tRNA synthetase from beef pancreas.

Authors:  L L Kisselev; O O Favorova; G K Kovaleva
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

Review 3.  Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.

Authors:  Sanchita Mukherjee; Mathewos Tessema; Angela Wandinger-Ness
Journal:  Circ Res       Date:  2006-03-31       Impact factor: 17.367

4.  A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.

Authors:  Keisuke Wakasugi; Bonnie M Slike; John Hood; Atsushi Otani; Karla L Ewalt; Martin Friedlander; David A Cheresh; Paul Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

5.  Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma.

Authors:  Ombretta Salvucci; Mark Basik; Lei Yao; Rossella Bianchi; Giovanna Tosato
Journal:  J Leukoc Biol       Date:  2004-04-01       Impact factor: 4.962

6.  Biologically active fragment of a human tRNA synthetase inhibits fluid shear stress-activated responses of endothelial cells.

Authors:  E Tzima; J S Reader; M Irani-Tehrani; K L Ewalt; M A Schwartz; P Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

7.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

8.  A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase.

Authors:  Jianming Liu; Eveline Shue; Karla L Ewalt; Paul Schimmel
Journal:  Nucleic Acids Res       Date:  2004-02-02       Impact factor: 16.971

9.  SIRT1 controls endothelial angiogenic functions during vascular growth.

Authors:  Michael Potente; Laleh Ghaeni; Danila Baldessari; Raul Mostoslavsky; Lothar Rossig; Franck Dequiedt; Judith Haendeler; Marina Mione; Elisabetta Dejana; Frederick W Alt; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Genes Dev       Date:  2007-10-15       Impact factor: 11.361
  9 in total
  6 in total

1.  Tris-2(hydroxyethyl)ammonium (2-methylphenoxy)acetate as an inhibitor of synthesis of acid cholesterol esterase of platelets and mononuclear cells.

Authors:  M M Rasulov; S N Bobkova; O A Belikova; M K Nurbekov; N P Shimanovskaya; M G Voronkov
Journal:  Dokl Biochem Biophys       Date:  2012-01-06       Impact factor: 0.788

2.  Tris-2(hydroxyethyl) ammonium 2-methylphenoxyacetate as an activator of aorta intima acid lipase.

Authors:  M G Voronkov; S N Bobkova; M M Rasulov; M K Nurbekov; O A Belikova
Journal:  Dokl Biochem Biophys       Date:  2011-11-19       Impact factor: 0.788

3.  Tris-2(hydroxyethyl) ammonium 2-methylphenoxyacetate as an inhibitor of synthesis of liver phospholipase A1.

Authors:  S N Bobkova; M M Rasulov; M K Nurbekov; O A Belikova; N P Shimanovskaya; M G Voronkov
Journal:  Dokl Biochem Biophys       Date:  2011-11-19       Impact factor: 0.788

4.  Tris-2(hydroxyethyl)ammonium (2-methylphenoxy)acetate as an inhibitor of synthesis of acid phospholipase A2 of mononuclear cells.

Authors:  M M Rasulov; S N Bobkova; O A Belikova; M K Nurbekov; M G Voronkov
Journal:  Dokl Biochem Biophys       Date:  2012-07-08       Impact factor: 0.788

5.  The complex of zinc bis-(2-methylphenoxyacetate) with tris-2(hydroxyethyl) amine as an activator of synthesis of total tryptophanyl-tRNA synthetase.

Authors:  M M Rasulov; M G Voronkov; M K Nurbekov; M V Zvereva; A N Mirskova; S N Adamovich; R G Mirskov
Journal:  Dokl Biochem Biophys       Date:  2012-07-08       Impact factor: 0.788

6.  Tris-2(hydroxyethyl)ammonium 2-methylphenoxyacetate activates the synthesis of mRNA aminoacyl-tRNA synthetase.

Authors:  M K Nurbekov; M M Rasulov; M G Voronkov; S N Bobkova; O A Belikova
Journal:  Dokl Biochem Biophys       Date:  2011-07-03       Impact factor: 0.788
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.